Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 26, No 17 (June 10), 2008: pp. 2883-2889
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.15.2702

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Peacock, C. D.
Right arrow Articles by Watkins, D. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peacock, C. D.
Right arrow Articles by Watkins, D. N.

REVIEW ARTICLE

Cancer Stem Cells and the Ontogeny of Lung Cancer

Craig D. Peacock, D. Neil Watkins

From the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

Corresponding author: D. Neil Watkins, MBBS, PhD, The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, 1550 Orleans St, Rm 546, Baltimore, MD 21231; e-mail: nwatkins{at}jhmi.edu

Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.

Supported by the Commonwealth Foundation, the National Cancer Institute/Specialized Program of Research Excellence (SPORE Grant No. P50CA058184), the Flight Attendant Medical Research Institute's Young Clinical Scientist Award (Grant No. 01250), and the Sidney Kimmel Cancer Foundation.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.






About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online